Holen Sie sich die Stockscreener-App
5.62
0.88%
-0.05
Handel nachbörslich:
5.65
0.03
+0.53%
Schlusskurs vom Vortag:
$5.67
Offen:
$5.52
24-Stunden-Volumen:
4.67M
Relative Volume:
0.83
Marktkapitalisierung:
$1.68B
Einnahmen:
$38.03M
Nettoeinkommen (Verlust:
$-146.40M
KGV:
-10.81
EPS:
-0.52
Netto-Cashflow:
$-121.38M
1W Leistung:
-2.60%
1M Leistung:
+25.73%
6M Leistung:
+130.33%
1J Leistung:
+123.02%
1-Tages-Spanne:
$5.3501
$5.80
1-Wochen-Bereich:
$5.3501
$6.515
52-Wochen-Spanne:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Firmenname
Abcellera Biologics Inc
Sektor
Branche
Telefon
(604) 559-9005
Adresse
150 W 4TH AVENUE, VANCOUVER
Vergleichen Sie ABCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.62 | 1.69B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-02-28 | Eingeleitet | Cowen | Outperform |
| 2022-12-15 | Eingeleitet | Goldman | Buy |
| 2022-11-16 | Eingeleitet | Truist | Buy |
| 2021-12-21 | Eingeleitet | The Benchmark Company | Buy |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Eingeleitet | Berenberg | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-05 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | Stifel | Buy |
Alle ansehen
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
Published on: 2025-10-14 11:10:04 - newser.com
Is now a turning point for AbCellera Biologics Inc.Portfolio Gains Report & Accurate Buy Signal Notifications - newser.com
How to use a screener to detect AbCellera Biologics Inc. breakoutsWeekly Stock Summary & Smart Swing Trading Techniques - newser.com
Analyzing recovery setups for AbCellera Biologics Inc. investorsQuarterly Trade Summary & Daily Price Action Insights - newser.com
What’s next for AbCellera Biologics Inc. stock priceWeekly Volume Report & Community Shared Stock Ideas - newser.com
Custom watchlist performance reports with AbCellera Biologics Inc.Trade Ideas & Low Risk Investment Opportunities - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025Market Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How AbCellera Biologics Inc. (8QQ) stock behaves in tightening cyclesEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Is AbCellera Biologics Inc. a candidate for recovery play2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
How AbCellera Biologics Inc. stock benefits from tech adoption2025 Year in Review & Daily Momentum Trading Reports - newser.com
AbCellera Biologics Hits New 52-Week High of $6.51 - Markets Mojo
AbCellera Biologics (NASDAQ:ABCL) Hits New 1-Year HighStill a Buy? - MarketBeat
Why AbCellera Biologics Inc. (8QQ) stock could rally stronglyNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
Analyzing AbCellera Biologics Inc. with risk reward ratio chartsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Real time alert setup for AbCellera Biologics Inc. performanceStop Loss & Weekly High Potential Stock Alerts - newser.com
Does AbCellera Biologics Inc. qualify in momentum factor screening2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Is AbCellera Biologics Inc. (8QQ) stock cheap vs fundamentalsWeekly Trend Report & Safe Swing Trade Setups - newser.com
Is AbCellera Biologics Inc. (8QQ) stock a top dividend aristocrat candidateEarnings Beat & Expert Curated Trade Setups - newser.com
AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 7.9%Here's What Happened - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 - PharmiWeb.com
AbCellera Biologics: Entering Growth Phase After A Pause (NASDAQ:ABCL) - Seeking Alpha
AbCellera Biologics Inc. recovery potential after sell off2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Is AbCellera Biologics Inc. stock a dividend growth opportunity2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Forecasting AbCellera Biologics Inc. price range with options dataJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Should you hold or exit AbCellera Biologics Inc. nowWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Statistical indicators supporting AbCellera Biologics Inc.’s strengthQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Leading vs lagging indicators on AbCellera Biologics Inc. performanceTrade Exit Summary & Short-Term High Return Ideas - newser.com
Is AbCellera Biologics Inc. stock safe for conservative investors2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Published on: 2025-10-05 03:44:08 - newser.com
AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price - Markets Mojo
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline - Yahoo
How high can AbCellera Biologics Inc. stock goRate Cut & Technical Pattern Recognition Alerts - newser.com
Using RSI to spot recovery in AbCellera Biologics Inc.Trade Volume Summary & Advanced Technical Analysis Signals - newser.com
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):